Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.
Clinical trial NCT03317236 · COMPLETED
Trial details
- NCT number
- NCT03317236
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2017-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.